Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5-Reference-Cited by-同舟云学术

Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5

Published:2013-10-26 Issue:12 Volume:4 Page:2302-2316
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Exertier Prisca¹²,Javerzat Sophie¹²,Wang Baigang³⁴,Franco Mélanie¹²,Herbert John⁵,Platonova Natalia¹²,Winandy Marie⁶,Pujol Nadège¹²,Nivelles Olivier⁷,Ormenese Sandra⁸,Godard Virginie¹²,Becker Jürgen⁴,Bicknell Roy⁵,Pineau Raphael⁹,Wilting Jörg⁴,Bikfalvi Andreas¹²,Hagedorn Martin¹²

Affiliation:

1. Univ. Bordeaux, LAMC, UMR 1029, F-33405 Talence, France

2. INSERM, LAMC, UMR 1029, F-33405 Talence, France

3. Ruhr-Universität Bochum, Medizinische Fakultät; Abt. f. Anatomie und Embryologie, D-44780 Bochum, Germany

4. Zentrum Anatomie, Abteilung Anatomie und Zellbiologie, Georg-August-Universität Goettingen, Germany

5. Molecular Angiogenesis Group, Institute of Biomedical Research, Univ Birmingham, Medical School, Edgbaston, Birmingham, UK

6. GIGA, Zebrafish Facility, Tour B34, Université de Liège, Belgium

7. GIGA, Unité de Biologie Moléculaire et Génie Génétique, Tour B34, Université de Liège, Belgium

8. GIGA, Imaging and Flow Cytometry Facility, Tour B34, Université de Liege, Belgium

9. Animalerie mutualisée, University of Bordeaux I, Talence, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights intoKIF11pathogenesis in Microcephaly-Lymphedema-Chorioretinopathy syndrome: a lymphatic perspective;2023-11-04

2. High expression of KIF20A in bladder cancer as a potential prognostic target for poor survival of renal cell carcinoma;Medicine;2023-01-13

3. Phenotype-Based Genetic Analysis Reveals Missing Heritability of KIF11-Related Retinopathy: Clinical and Genetic Findings;Genes;2023-01-13

4. Advances in the discovery of DHPMs as Eg5 inhibitors for the management of breast cancer and glioblastoma: A review;Results in Chemistry;2023-01

5. REMOVED: Advances in the discovery of DHPMs as Eg5 inhibitors for the management of breast cancer;Dihydropyrimidinones as Potent Anticancer Agents;2023